Rukobia 600 mg prolonged-release tablets

*
Pharmacy Only: Prescription
  • Company:

    ViiV Healthcare BV
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

qrcode image

Scan the QR code or enter an email to access and share this medicine:

Updated on 15 September 2025

File name

ie-pl-combined-rukobia-issue6draft1-clean-no headers.pdf

Reasons for updating

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

Changes following Renewal Application

Section 6 - What Rukobia looks like - deletion of 'film coated'

Minor administrative updates to addresses

Updated on 15 September 2025

File name

ie-spc-combined-rukobia-issue7draft1-clean-no headers.pdf

Reasons for updating

  • Change to section 3 - Pharmaceutical form
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Changes following Renewal Application -

Section 3 - deletion of 'film coated' 

Section 4.8 - deletion of 'treatment emergent' and minor administrative amendments

Section 9 - addition of last renewal date

Section - Update of last revision date


Updated on 28 November 2024

File name

ie-spc-combined-rukobia-issue6draft1med.ie.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Launch of Rukobia in Ireland

Updated on 28 November 2024

File name

ie-pl-combined-rukobia-issue5draft1 medie.pdf

Reasons for updating

  • New PIL for new product

Free text change information supplied by the pharmaceutical company

Launch of Rukobia

ViiV Healthcare BV

ViiV Healthcare BV
  • Address:

    12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
  • Telephone:

    +353 1 495 5000
  • Medical Information Direct Line:

    1 800 244 255